A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects

Clinical trial NCT05995444 · COMPLETED

Trial details

NCT number: NCT05995444
Sponsor: AN2 Therapeutics, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-06-05
Primary completion: 2023-07-26
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.